Good morning.
Futures grinding higher, SPX +0.3% — MSFT single-handedly carrying the tape (+3% AH, 49 handles of SPX move). META keeps bleeding, now down 11 straight sessions and another -1% in after-hours. AMZN +2% on AWS reacceleration to 37% growth, but the FCF TTM OUTFLOW OF -$7.6B is getting hand-waved. Asia mixed: Taiwan semis flat, Korea memory names off 1-2% on the Situational Awareness unwind — forced liquidation, not fundamentals.
Three themes define the day:
1. Capex bifurcation is the new alpha. MSFT kept CY26 guide unchanged at $175B and got rewarded +4% (Azure 43% cc, Copilot 30M seats). META and GOOGL raised and got destroyed. The market is now pricing capex efficiency, not just absolute spend. MSFT +, META/GOOGL –.
2. Memory inflation is a feature, not a bug. AMZN explicitly blamed "the higher cost of memory" for the $20B capEx hike. MU/SK Hynix/ASE pricing power intact. Apple's "100-year flood" on memory procurement confirms no demand destruction yet. FormFactor and Cohu benefit as test capacity becomes the new binding constraint.
3. Infrastructure scarcity deepens. PWR's $53B backlog with 95% of large generation work NOT yet in backlog — gas turbine lead times at 5-6 years. AXTI record InP revenue at $30.7M, backlog well over $100M, targeting gross margins starting with a 5. The 800G/1.6T optical cycle is steeper than anyone modeled.
Situational Awareness liquidating its entire $16B public book in a block to Citadel is the technical elephant in the room — explains recent memory/momentum weakness. At least 4-5 hedge funds with massive TRS exposure to those names. Stay aware of contagion risk into close.
We'll hit up MSFT, MU, and AMZN first, then get to infrastructure (PWR, AXTI, COHU) and internet (META, GOOGL).
The story isn't bad execution. It's bad sequencing. Meta delivered a Q2 revenue beat (27% ex-FX growth, $60.8B vs ~$60.2B consensus). Core ads are humming — impressions +14%, price +12%. But the market hates the gap between when the spend hits and when the revenue shows up. Stock is within a hair of its 52-week low at $536.
The debate has collapsed to one question: Can AI revenue scale fast enough to offset the $130-145B capex bill? No one has the answer. Everyone is cutting PTs.
Street PTs are being rewritten lower, fast. The cluster shifted from a prior $700-930 range to a new band of $595 (Wedbush) to $883 (Rosenblatt). The median is probably around $700-750. Most maintained ratings (Buy/Outperform), but they're lowering multiples and acknowledging the timeline mismatch.
The consensus narrative is not that the business is broken. It's that the rate of change in spending is outpacing the rate of change in revenue visibility. And management didn't give the market a bridge to 2027.
Core business is a cash machine. 82% gross margins. $228B LTM revenue. AI is already working inside the ad business — mid-teens conversion improvement on Facebook, double-digit time spent gains on Instagram. Management outlined multiple new revenue streams: Business Agents (1M accounts in month one, paid monetization starts Aug 1), compute/API sales, enterprise AI tools, WhatsApp messaging. CEO says they're "getting offers for compute at a significant premium." The bull case is that 2027-2028 revenue gets a material lift not in consensus today.
"Meta provided its clearest roadmap yet for monetizing AI beyond ads, which should increase confidence in the long-term ROI of AI investments." — Scotiabank (even as they cut PT to $600)
"The 3.6 billion user base gives Meta a consumer AI distribution advantage no hyperscaler has." — Bernstein
The spend is real and immediate. $130-145B capex this year. Wolfe is modeling $233B in 2027 (6-7GW of capacity). Internal token costs alone added ~$2B to R&D y/y (per Wells Fargo). OpEx growth is running at 67% on R&D from AI talent and third-party token costs. Margins compressed 620bps. The Q3 guide of ~22% growth is a deceleration. And there's zero visibility on 2027 capex — management explicitly declined to give a number. The bear view: this is a utility-like spend cycle with option-like revenue. Timing mismatch could last 18-24 months.
"The key valuation debate remains whether AI revenue can scale quickly enough to offset sustained AI investment. Monetization remains prospective while spending is immediate." — Scotiabank
"Meta did not deliver definitive plans to sell compute. They suggested they'd have 'more to share on all of this soon.'" — Mizuho
"Meta is early in most of its strategic monetization efforts. We expect continued strong growth in capex to build out these initiatives, resulting in a longer-term period for ROIC on that spending." — Wedbush (Neutral, PT $595)
"The reported and guided figures will be interpreted as a solid indicator of the application of AI compute to Meta's core business but not quite the outsized positive returns expected in recent weeks." — Goldman Sachs
"Meta is currently monetizing at near $0 per gigawatt, below hyperscaler peers at $15B and AI lab peers closer to $50B per gigawatt. New AI revenue begins materializing by end of 2026 and accelerates in 2027." — Barclays
Verdict: Azure acceleration + Copilot doubling = the AI thesis just got a massive data point. Street overwhelmingly bullish, but that valuation debate isn't going away. Stock opens up ~5% post-print.
13 firms raised/reiterated, PTs ranging $500 (BofA) to $647 (Bernstein) – a $147 spread that tells you everything about how much optionality people are baking in. The cluster: most land between $522 and $550. Consensus is Azure 43% is the cleanest beat in a year, and the 45% guide is the biggest upward revision since Q4 2025. Barclays the lone PT cut ($545→$512), but even they stay Overweight – that's a valuation call, not a fundamental one.
Multiple firms flag the PEG of 0.78 and trailing P/E of 23.7x as cheap relative to growth. Bernstein explicitly says the stock "remains undervalued." The bull camp is leaning hard on the optionality argument.
Incremental:
BULL: The AI monetization loop is real. Copilot seats doubling in a quarter and usage-based credit consumption up 4x QoQ proves enterprise adoption is inflecting. Azure's re-acceleration validates that AI workloads are additive, not cannibalistic. With 450M+ M365 seats still unpenetrated, CLSA's "cleanest optionality in AI" isn't hype – it's math. Margins held at 67.2% GM despite heavy build. Capex stays below cloud revenue growth. RPO conversion gives 12-18 months of visibility. At 23x forward P/E with 18% revenue growth, the stock is cheap for a platform shifting from legacy to AI-native.
BEAR: The valuation debate is real. Barclays cut PT not because of bad numbers, but because 30x+ forward earnings (on some metrics) is already pricing in perfection. Azure's 45% guide implies acceleration, but comps get harder. Margin pressure from lower-margin AI workloads and extended depreciation accounting only masks the real cash cost. PC weakness (Windows OEM -7%) and Xbox impairments add friction. The capex trajectory – $175B+ in CY26, with no near-term pullback – will keep FCF below pre-AI levels. And if demand eventually normalizes, that capacity overhang turns into a drag. "Clean optionality" cuts both ways if the conversion slows.
Bottom line: bulls win this quarter. The debate is about duration, not direction.
"Microsoft holds one of the cleanest optionalities in AI – conversion of its 450M+ M365 seats to Copilot paying seats." – CLSA (on the long-duration tail)
"The key takeaway is increasing validation of Microsoft’s AI strategy, highlighting broad-based AI demand and strong revenue visibility from RPO conversion." – BofA (the most succinct bull case)
"These data points push back on the AI disruption narrative." – Oppenheimer (directly addressing the "networks get disintermediated" fear)
"The stock remains undervalued despite the expected market move at the opening." – Bernstein (conviction call at the highest PT)
"Each major debate point – Azure, capex, M365, margins – turned out in line or better than expected." – UBS (clean read on the quarter's completeness)
Hyperscaler peers (AMZN, GOOGL): This is a positive read-through. If Azure can accelerate into a capacity-constrained environment, AWS and GCP are likely seeing similar dynamics. Expect the "cap-ex is going to be rewarded" narrative to get louder. Watch for earnings.
AI infrastructure (NVDA, ANET, MRVL): Microsoft added 1 GW of capacity in the quarter, 3 GW TTM. They guided $50B+ in quarterly capex. This is a massive demand signal for GPUs, networking, and data center build-out. The supply-constraint language also means demand is exceeding current install – good for pricing power.
Enterprise software peers (CRM, NOW, ADBE): Copilot adoption trajectory is the benchmark. If Microsoft is getting 10M net adds in a quarter, the message is clear: enterprise AI is happening through the incumbent platforms, not disruptors. That's a mild negative for pure-plays, positive for platform stories.
Thematic take: The "frontier lab contracts" are dropping out, but "regular business" is picking up the slack. That's the sign of a durable demand cycle, not a hype wave. Rate of change is positive. Play the ecosystem, not just the name.
One worry: the capex accounting change (extending asset life) inflates operating income. Watch the cash flow trajectory. FCF guided positive for FY27, but we're still 12+ months out from free cash generation matching the investment pace. That's the one number the bears will hang their hat on.
Verdict: Fortinet just ripped the face off Q2. Billings accelerated for the second straight quarter, product revenue exploded +52%, and they raised FY26 guidance across every metric. The stock is up 93% YTD and the street is scrambling to re-price. But there’s a debate forming around how much of this is real demand vs price-driven pull-forward. PMs should own it but watch the 2027 setup.
Q2 billings $2.37B (+33% y/y) — that’s the fastest in 16 quarters. Revenue $2.05B (+26%), product revenue $773M (+52%). Operating margin 38.0%, a Q2 record. EPS $0.90 vs street $0.73. Every number smashed.
Guidance raised: FY26 revenue now ~19% (was ~15%), billings ~25% (was ~18%). Service revenue growth inflected after Q1 was the low point.
PTs moved to $163-195 — previously clustered ~$102-185. Consensus is bullish but not uniform:
Bull case: This is a structural re-rating. AI infrastructure buildouts are driving demand for high-performance FortiGate appliances — customers need to protect east-west traffic in data centers and enable OT/IT convergence. Fortinet is taking share from cloud-only SASE players (they lack the hardware). Service revenue is accelerating into 2027. Margins are expanding (80% gross, 38% op). Management is executing at a level that warrants a premium multiple.
“The product cycle is durable rather than a pull forward, supported by AI infrastructure buildouts, OT convergence with IT networks, and share gains against cloud-only SASE competitors.” — Cantor Fitzgerald
Bear case: Price increases are doing a lot of the heavy lifting. Fortinet raised prices 10-20% on most hardware in May, after a 5-10% hike in March. Stifel estimates high single-digit billings tailwind from price alone. Customers may have pulled forward demand ahead of further increases. Scotiabank flags a “growth hangover” in 2027. New demand areas (agentic east-west traffic, AI datacenter deals, OT) are still unproven at scale.
“We are awaiting evidence that new areas of demand… are sustainable before shares can re-rate higher.” — Scotiabank
Strong read-through for network security incumbents (PANW, CHKP) — AI infrastructure demand is pulling through hardware refreshes. But also a caution: if price increases are masking organic deceleration, then comps get harder into 2027. Watch for service revenue mix as the tell — that’s the cleanest proxy for real stickiness.
The “AI networking” theme is real, but Fortinet’s product cycle is also a reminder that this bull case has a shorter half-life than SaaS subscription growth. PMs should own it, but take profits into strength when the service revenue acceleration narrative gets fully priced.
Verdict: Best-in-class enterprise AI infrastructure play with the narrative and the numbers to back it up. The Q2 beat and massive upward revision to the 2027-2029 framework reset the debate — this is no longer just a hyperscaler land-grab story. But at 70x P/E and negative FCF, the market is paying for perfection. The risk/reward is uncomfortable for PMs who missed the first 33% move.
Four analysts raised PTs yesterday — Scotiabank to $1,208, Cantor to $1,211, UBS and Stifel both to $1,265. Range: $1,208 – $1,265. Current price ~$1,056. Only Scotiabank is at Sector Perform; the other three are Buy/Overweight. The cluster is tight — nobody is calling a top, even the hold-rated target sits 14% above the close.
Collective thesis: AI inference is the next growth wave, and EQIX owns the enterprise interconnection layer. The Q2 beat was broad (rev $2.62B vs $2.59B consensus, AFFOps $11.78 vs $11.35). But what matters more is the step-change in the medium-term framework:
"Higher capital expenditure spending and a larger development pipeline will give the company the means to capture demand and accelerate revenue and earnings growth." — UBS
EQIX is positioned at the intersection of two powerful secular trends: enterprise digitization and the shift from AI training to inference. Cheaper intelligence (open-weight models, agentic AI) drives more deployments in colocation — not just hyperscale cloud. EQIX’s interconnection fabric makes it indispensable.
"Cheaper intelligence will sustain enterprise adoption and token growth while open weight models drive demand for private infrastructure. Model fungibility should lead to larger, more complex deployments with increasing connectivity density." — UBS
The capex step-up is not reckless — it's targeted at the top 25 metro areas where supply constraints are acute. Cantor expects a mid-20% yield on gross capex. Given booking velocity and pricing power, that math works.
"AI is accelerating the digitization activities of customers’ workloads, and the shift to inference is happening faster than expected." — Cantor
Bookings acceleration (TTM basis) and the raised guide tell you demand is real, not a one-off bump. The xScale program is firing on all cylinders — 134 MW in a single quarter is a record.
70x P/E on a REIT that just generated negative free cash flow. The premium is pricing in a straight-line ramp that leaves zero room for error. The Q2 beat was inflated by xScale leasing fees — call it ~$120M in non-recurring revenue. Strip that out and the beat is more modest.
CapEx going from $3.5B to $6B is a 70% increase — and they're committing to that for the next three years. If demand inflects (macro slowdown, AI capex cycle peak), EQIX is left holding a massive development pipeline with high financing costs. FCF could stay negative for years.
"The new target remains below the stock’s current valuation, which trades at a P/E ratio of 70.56, reflecting premium valuations in the AI infrastructure space." — Scotiabank (Sector Perform)
Valuation is the elephant. This is not a value debate — it's a momentum and positioning question. If the AI trade rotates or rates move higher, the multiple compression could be violent on a name that's already up 33% YTD.
EQIX is the enterprise AI infrastructure bellwether — whatever happens in colocation, interconnection, and private AI deployments flows through this name. Peers to watch: DLR (more hyperscale exposure, lower margin), CONE (smaller, purer retail colo), IRM (digital REIT, different thesis). On the compute side, AMZN, MSFT, GOOGL are both customers and competitors — EQIX's xScale JVs with them are symbiotic, but the hyperscalers are also building their own edge presence.
Thematically: This report validates the "inference is the next phase" narrative. Token growth + agentic AI means workloads leave the training cluster and land on latency-sensitive, regulated, or enterprise-controlled infrastructure. EQIX is the tollbooth.
One to own, not to chase. The setup is good — raised guide, accelerating bookings, pricing power, AI tailwinds. But after a 33% YTD run, the easy money is made. For PMs with a medium-term horizon, this is a name to add on weakness, not press buys at $1,056. If you're short, you're fighting the narrative and the data.
Verdict: ARM printed a clean beat — EPS +12% above consensus, SepQ guide +7% — but the stock got absolutely hammered (-20% in a week). Why? The royalty story hit a speed bump: smartphone weakness spreading from low-end to mid/high-end, forcing FY royalty growth guide down to high-teens from 20%. That spooked a multiple already stretched at 277x P/E. But the AGI narrative is accelerating. $2B+ of demand sighted, $1B of capacity secured. This is a tug-of-war between a premium that can’t breathe and a transformational AI thesis that’s getting real. For now, multiple compression wins the round.
PTs are all over the map — literally $255 to $500. The median clusters around $320 (Evercore $326, Jefferies $320), with the bull camp (TD Cowen $475, UBS $470, Bernstein $500) betting on AGI CPU capturing a massive TAM shift from GPU to CPU. The cautious crew (Guggenheim $255, BofA $260, Wells $280) all cite valuation — “multiple compression” is the common enemy. Consensus FY27 revenue sits at ~$6B, slightly above the company’s own guide. The street is baking in AGI CPU revenue of $1-2B by FY28, which is the key variable.
“Arm is one of three or four companies seeing clear-cut benefits from the AI paradigm shift and resulting infrastructure build-out.” — Guggenheim
“[The] softer Royalty guidance is more than offset by Arm’s second-quarter License revenue acceleration guidance of 30% year-over-year growth.” — Guggenheim
“Investor expectations remain high and overall supply constraints cap any near-term upside.” — BofA (on their Neutral rating)
“We expect limited change to consensus estimates and anticipate shares will be driven by AGI momentum and the company’s ability to meet demand.” — Wells Fargo
ARM’s split personality matters for the whole semiconductor landscape. If AGI CPU thesis works, it forces a rethink on who captures AI inference spend. AMD and NVDA are the incumbents in GPU compute — ARM is an architecture challenge, not a direct competitor yet. But TD Cowen noted “AI workloads shifting from GPUs to CPUs” — that’s a shot across the bow. For QCOM and MTK, ARM’s smartphone weakness is a canary: if mid/high-end handsets are rolling over, those names will feel it too (both report next week). For the broader semis, ARM’s multiple compression is a warning — if a 97.5% gross margin, 25% grower with an AI halo gets cut 20% on one royalty guide revision, nobody is safe from the de-rating steamroller.
Verdict: QCOM is a battleground. PT range is wider than a Texas highway — Cantor at $165, Rosenblatt at $235, Baird at $400. Stock at $150-155 means the market is pricing in the bear case. Bulls think Apple's exit is the unlock for diversification. Bears see margin compression and a crowded accelerator market that doesn't need another player. Rate of change on the bull case is accelerating, but near-term EPS is getting cut.
Three firms, three radically different conclusions after the same print. Let's collapse it:
Bull case (Baird/Rosenblatt): Apple modem is a known quantity now. QCT margins trough in H1 FY27, then recover. The diversification story is real — $5B DC revenue, auto, IoT, edge AI. 20x forward EPS on a growing base is cheap. Agentic AI drives handset replacement cycle in 2028. The $400 target implies you're paying for a structural re-rate, not just earnings growth.
Bear case (Cantor): The "diversification" is a fancy word for entering lower-margin, hyper-competitive markets. Accelerator/CPU is dominated by NVDA/AMD. Custom ASIC margins are dogshit. Handset is still 60%+ of revenue and the market is flat to down. Apple exit cuts ~$4B in revenue and ~$2B in profit over the next 18 months. EPS reset is real — FY27 estimates came down 13%+ from prior. At 16x, stock is "fair" but has no catalyst.
"Revenue diversification is at a turning point, with data center revenue expected to reach $5 billion in fiscal 2027, representing 11% of total revenue estimates. We believe agentic-AI run smartphones could mark the beginning of a unit and content rebound starting in 2028."
That's Baird planting the flag. $400 implies the market is missing the next leg. Cantor sees a $165 ceiling. Reality is probably somewhere in the middle — but the rate of change on the bull case is improving faster than the consensus EPS revisions suggest. Worth watching. Not ready to swing unless QCT margins show a trough signal.
VERDICT: TENB IS A SHOW-ME STORY TRADING AT A CROSSROADS. Revenue beat, Tenable One traction, first q/q net dollar expansion improvement since 1Q22 — all real positives. But subscription growth decelerating to 8.9% is the elephant in the room. Stock up 43% in six months, now at $31.48. Analyst camp splits: Needham sees upside to $36, Piper says Neutral and cuts to $30. The bull case rests on stabilization, the bear case on whether stabilization is enough.
Three houses, three takes. Consolidated narrative:
BULL (Needham + momentum traders): Tenable One is scaling, NDE is stabilizing, billings guidance improved — the narrative is shifting from "how bad is the deceleration" to "is the floor in." If NDE ticks up again next quarter, the multiple re-rates.
BEAR (Piper + skeptics): 8.9% sub growth is the core metric. Mythos tailwinds are not showing up near-term. Competition from non-traditional VM vendors (MSFT? CrowdStrike?) is real. "High-single-digit growth" in a sector paying 20-30x NTM revenue for peers — that math doesn't work without acceleration.
From Stifel – the most balanced take, and the only one that gives you the full trade-off:
"Net/net, we are pleased to see ongoing Tenable One traction and continued early AI-related tailwinds. While shares not expensive, we remain cautious on how the VM space will evolve over time, especially given cross-currents and increased competitive noise from non-traditional vendors and continued mixed feedback on the group from our channel checks. TP to $31."
Bottom line: TENB is a hold-your-nose call unless you believe NDE continues to inflect. Stock has already repriced from the low-$20s to $31 — the easy money is done. Next catalyst: next quarter's NDE and Tenable One mix. If NDE goes back to 105% or below, this thing sells off. If it holds 106%+ and sub growth stabilizes, Needham's $36 looks achievable. Right now? Edge goes to the sidelines or small long with a tight stop.
Verdict: The stock just printed a $1B revenue quarter for the first time, guided to ~100% growth, and promptly dropped 24% in a week. The pullback reopens the risk/reward for believers, but the bear case isn't dead – it's just been pushed to 2027.
Bloom Energy delivered the quarter every fuel cell bull dreamed of: revenue of $1.06B vs $815M consensus, adjusted EBITDA of $253M (67% above the Street), and guidance that implies roughly 100% top-line growth for FY26. The stock ripped 335% over the prior twelve months, then gave back a quarter of that in seven days.
Mizuho upgraded to Outperform from Neutral today, citing "attractive valuation" after the pullback. Their PT goes to $242 (from $285) – the cut is purely mechanical (service revenue run-rate correction + modest peer multiple compression). They see Bloom as a "differentiated onsite power solution" with $27B+ in financing capacity and validation from all major hyperscalers.
Truist, meanwhile, cut to $218 from $250, maintaining Hold. They like the near-term execution but worry about the penetration opportunity: customer conversations are about "filling power gaps" not a structural shift to microgrids. That caps Bloom's addressable market within the 30-40 GW of greenfield hyperscale capacity expected in 2027.
"The company reported a beat-and-raise quarter for the second quarter of 2026 and now expects approximately 100% revenue growth in 2026. The revenue growth is driven by behind-the-meter data center demand." — Truist note
This is real. The backlog continues to outgrow revenue. New Mexico permitting is incrementally positive. The "time-to-power advantage" – i.e., ability to plug in a fuel cell faster than grid interconnection – is the killer app for desperate hyperscalers.
But the question isn't Q2 or Q3. It's whether this is a one-trick (peak) data center cycle play or a multi-year platform shift. Truist is saying the former. Mizuho is saying the latter, but pricing in some multiple compression.
Bull case: The beat was not a fluke – it's a function of structural demand. $27B in financing means they can scale without diluting. Every major hyperscaler (AWS, Microsoft, Google) is a customer. Guidance was raised. The pullback resets valuation to a point where upgraded estimates support upside. Mizuho: "Revenue and shipments exceeded expectations, operating leverage materialized earlier than anticipated." Bernstein and Morgan Stanley both raised PTs (to $282 and $310 respectively). Clear Street upgraded to Buy.
Bear case: The market is pricing in perfection. 380% in a year, then a 24% one-week drawdown – that's momentum unwinding, not a buying opportunity. Truist's point: this is power gap-filling, not a greenfield paradigm shift. Greenfield data centers will use grid power, not fuel cells. Peer multiple compression (GE, CAT, etc.) is a headwind. If the growth rate decelerates in 2027, the stock has much further to fall. The Mizuho PT cut – even on an upgrade – is a tell.
Sector-wide, the consensus is more constructive than the price action suggests. Morgan Stanley still at $310 Overweight. Clear Street $290 Buy. Bernstein $282 Market Perform. But both Truist ($218 Hold) and Oppenheimer (Perform) are staying on the sidelines. The bottleneck isn't demand – it's the addressable market ceiling.
Bottom line: if you think hyperscalers will adopt fuel cells as a permanent architecture, this is the dip to buy. If you think they'll revert to grid + batteries once interconnection queues clear (sometime in 2027-2028), take the gain and wait. The rate of change in the narrative is still positive – but the rate of change in the stock price went negative fast. That's the trade.
UBS is calling the bottom on SK Hynix ADRs — initiating Buy with a $204 target (61% upside from $126.79). Their thesis: the current price bakes in a 17.7% ROE forever, but they see average ROE of 40.2% from 2027-2031. Agentic AI drives DRAM bit demand growth to 36% YoY in 2027 (from 22% in 2026). Stock is down 33% from its July peak and trading just above its 52-week low — ugly positioning meets a real catalyst.
"The current valuation discounts a long-term return on equity of 17.7%, in line with the post-DRAM consolidation average from 2012 to 2022."
The recent Q2 revenue print (KRW 79.3T, +257% YoY) was a record, but the Korea single-stock leverage ETF crackdown adds headline noise. Not sure that matters for the fundamental story. This is a memory semi play where the cycle math is asymmetric, and UBS is making a clear r/r call — buy the trough when the narrative is still broken.
Verdict: Show-me story on merger execution. UBS nudged PT to $70 (from $65) but stays Neutral. BofA still at $65 with Underperform — they see upside if the deal works, but flag execution risk. The gap between those two views is the entire debate.
The quarter itself was fine — revenue $935M beat by ~$9M, EPS $1.08 vs $1.03 consensus. Guidance in line. The miss relative to UBS’s model was in broad markets (consumer edge / IoT, ~45% of that segment) which dipped QoQ in CQ3. That’s noise, not a thesis-breaker.
The real signal is post-deal. New management structure is set. Visibility on closing by end of September. UBS sees the combined entity repositioning parts of the QRVO portfolio into growth markets that have expanded since the deal was announced. They now model pro-forma EPS of $5.17 for CY2027. At $70 that’s ~13.5x — cheap for the end-market breadth.
“Skyworks could emerge as an inexpensive semiconductor stock with exposure to a broad array of end markets.” — UBS
The bear case (BofA via the article): Merger execution is hard. The stock has been a value trap before. We need to see revenue synergies materialize before giving credit. The Underperform rating says the risk/reward isn't there yet.
Our take: SWKS is a play on the rate of change in post-merger reorganization, not on next quarter's revenue. The stock trades at 25.4x standalone EPS but the pro-forma multiple is lower. If the integration narrative gains traction, that multiple compression could unwind fast. But it’s a second-half 2026 story, not a Q4 catalyst. PMs looking for a cheap semi with optionality can size in small, but the weight-of-evidence right now is "wait for the close."
UBS isn't blinking. Reiterates Buy, $370 PT after Q2 revenue miss that sent the stock down 26% in a week (now $231). The miss was timing — supply chain congestion pushing revenue into H2, not demand destruction. Underlying op profit actually met, and they raised full-year organic growth guidance to the high end. Q3 guided ~35% organic growth, double Q2's level. That's a massive ramp that should put estimates moving higher.
"UBS expects estimates to move higher despite the second-quarter miss, though with a larger second-half ramp now anticipated."
The thesis is clean: AI power infrastructure demand is accelerating, not fading. The revenue miss is a timing shift, not a signal. Strong Buy consensus intact. Worth watching the Q3 print — if they execute, this dip gets bought hard. If not, the multiple compression (stock still up 55% YoY) has further room to run.
BUY-SIDE TAKE: DDOG is the software name to own into earnings next week. BofA just slapped a top-pick tag on it ahead of the August 6 print, $305 PT, and the stock's already up 77% in a year — closing in on a fresh high at $264. The thesis is simple: AI spend is real, demand data looks healthy, and a recent OpenAI incident gave the Street a reminder of why observability matters when things break. BofA acknowledges the nosebleed valuation (P/E > 710x) but argues high-quality growth assets are too scarce to ignore in software right now.
"High-quality growth assets remain scarce across the software sector."
Multiple firms have converged on $300 PTs (Morgan Stanley, Citi, Guggenheim) with TD Cowen calling for mid-30% revenue growth vs. guidance of 30%. The renewal dynamics BofA flagged are the swing factor — large customer cohorts rolling over could juice the print or spook the tape if churn creeps. But the consensus betting line is bullish, and the OpenAI tailwind (visibility after an outage) is a fresh narrative edge that wasn't there last quarter.
The signal: DDOG is crowded on the long side, but the rate of change is still accelerating. If the beat-and-raise is clean, this thing rips to $300+. The risk is expectations already priced in — 77% gains leave little room for a "good but not great" quarter. PMs should size accordingly given the upcoming binary event.
THE UPGRADE MAKES SENSE. CORZ cratered 24% in a week to $21.95 — Freedom Broker just upgraded from Hold to Buy with a $33 PT. They were Hold at $30 before; now they see the AMD deal as a game changer. AMD added 530 MW of leased power to CoreWeave’s 590 MW base, and the company is billing for 437 MW already. Only 150 MW left to deliver on the CoreWeave contract by early 2027. That’s a $10B+ revenue stream locked in for 12 years.
"Core Scientific is on pace to deliver CoreWeave’s 590 megawatts of power by early 2027, with only 150 megawatts remaining at the end of the quarter."
THE MATH GETS BIGGER. AMD deal adds another $14B in base contracted revenue (with 2.5% annual escalators). Total contracted power now 1.1 GW, $24B revenue backlog. Meanwhile, a handful of other firms raised PTs to $35-38 (Compass Point, Canaccord, Needham, Macquarie, BTIG) after Q2 revenue of $164M beat estimates. The bear argument? The stock is still oversold per RSI, and the last fall’s capacity delay spooked CoreWeave enough to cut its 2025 forecast. But the rate of change on the capacity ramp is positive — 437 MW already billing, 150 MW to go. PMs should watch for any hiccup on the remaining build-out timeline. Net net: the risk/reward shifts at $22 with a $33+ PT cluster.
Verdict: Buy the pullback. Stock off 30% from its $1,145 high after a blowout FQ4 — EPS $5.71 vs $5.09, rev $3.63B (+48% YoY), gross margin 52.7%, record FCF of $3.1B for the year. Multiple analysts raising PTs in unison: TD Cowen to $1,000 (from $850), Rosenblatt to $1,400, Bernstein to $1,350, Morgan Stanley to $1,187. The collective thesis: HAMR is real, mass-capacity demand is structural, and HDDs have less double ordering risk than other components.
"hard disk drives represent one of the few areas with lower double ordering risk and supply discipline."
Guidance beat buy-side expectations, and management’s confidence in longer-term demand improved. But TD Cowen flags positive EPS revisions will likely be less pronounced going forward. Bear case: 172% YTD gains + InvestingPro fair value suggesting overvaluation means good news is already in the price. PMs: this is a structural HDD cycle play, not a momentum chase. Supply discipline makes the risk/reward asymmetric on pullbacks.
UBS cuts PT to $196 from $228 but stays Buy – they're just recalibrating on fiber timing, not flipping the thesis. Estimates trimmed 3% for '27 and 9% for '28, but still 4% and 19% above consensus. The key number: 40% EPS CAGR through decade end. Stock's been hammered – down 18% in the past week, now at ~$127 with a P/E of 58x but a PEG of 0.46. That's absurdly cheap if the growth materializes.
"The stock has experienced significant de-rating over the last month, making valuation more attractive with longer-term growth not priced in."
UBS likes the pivot to long-term offtake contracts – limits peak margin expansion but gives earnings visibility. Q2 beat (EPS $0.78 vs $0.75 est, rev $4.74B vs $4.62B) got ignored as the market frets about near-term optical ramp. At 28x '27 and 18x '28 UBS estimates, the r/r is compelling if you believe in the photonics story.
Needham lifts BHE to $90 (from $80) after a Q2 that crushed. Revenue 5% above consensus, EPS beat by 9%. Management now guiding FY rev to $3B – a record – with growth of 13% vs prior 9-10%. The P/E is 79.77x, but the growth trajectory and margin momentum make it a classic "pay up for compounding" name.
"Management now projects full-year growth of 13% versus prior expectations of 9% to 10% growth, with EPS expected to outpace the improved top-line growth."
Key drivers: Semi-Cap & A&D ramp in second half, Advanced Computing & Comms staying strong, Medical double-digit. Cash conversion cycle dropped to 59 days – operational efficiency is real. The only soft spot is A&D (transition year). Needham raised 2026/2027 estimates. This isn't a one-quarter pop; the rate of change in guidance is what PMs should own.
Stifel bumps PT to $130 (from $120), but keeps it at Hold — and the stock is already sitting at $128.22. Not exactly a screaming buy. The tension is clear: Emerging Tech ARR grew 40%+ YoY and billings +35%, but the core firewall appliance business is dragging (product revenue -14% in Q2). SASE growth also decelerated. Revenue missed the midpoint of guidance for the second straight quarter — first time in five years. Q3 guide was soft, but management is banking on Q4 product revenue returning to YoY growth. Another price increase coming in weeks. The bull case rests entirely on a backend-loaded FY26 and a pivot to higher-margin subscription/emerging tech. The bear case: hardware is a structural headwind and Q2’s EPS beat ($2.55 vs $2.45) is a mirage if revenue keeps slipping.
“The company delivered mixed results with revenue missing the midpoint of guidance for the second consecutive quarter, marking the first such occurrence in over five years. The miss was attributed to lower demand for firewall appliances, while SASE growth also decelerated.”
Gross margin still elite at 87.66%, and the $2B buyback expansion adds a floor. But at $128, the r/r is balanced — not a conviction name, just a steady Eddie with an inflection point that hasn’t arrived yet.
Cantor Fitzgerald bumps GNRC PT to $333 from $325 (Overweight), aligning with a consensus that still sees ~46% upside. Thesis is straightforward: shorter lead times got Generac in the door on data center backup power, but management convinced the firm its moat is real — cost structure, custom design, direct commissioning/service. Early customers happy with delivery and responsiveness. This is a hold-the-relationship story, not just a first-mover-wins narrative.
"Lead times won Generac the initial opportunity, while execution and service can help preserve customer relationships."
Needham also reiterated Buy at $282, which is more conservative but acknowledges the core beat (Q2 EPS $2.91 vs $2.00 est, aided by a $71M tariff refund). Revenue slightly light at $1.17B vs $1.18B consensus — noise. The durable point: even stripping out the refund, adjusted EBITDA (~$220M) inline with estimates. Data center ramp + residential recovery later in cycle = clean setup if execution holds.
VRNS is a classic "print beat, narrative miss" story – and the buy-side is holding the line. Q2 SaaS net new ARR ex-conversions landed at $31.5M, above the high end of guidance but below the Street's mid-$30M bogey. Management pinned the shortfall on Thoma Bravo takeout rumors that surfaced in the final week of the quarter, causing a handful of large deals (including a seven-figure one) to slip into July. The stock gapped down 15% after-hours then recovered half the loss.
"Some of those deals, including a seven-figure transaction, closed in July."
Three shops (D.A. Davidson, Cantor, Needham) all stay long – PTs cluster at $50-55, with Needham raising from $40 and the others holding. Full-year guidance for SaaS net new ARR ex-conversions got raised by ~$10M, roughly 2x the Q2 beat. That’s a signal: management sees the pipeline intact, not impaired. The underlying SaaS transition (ARR up 25% YoY, gross margins 78%) is still compounding. Near-term noise from M&A rumors is a distraction, not a thesis-breaker.
FICO taking a hit in the aftermarket despite an earnings beat and a guidance raise. The tape is focused on the wrong things – revenue miss (tiny, $2.4M), debt load, capital allocation. PMs should ignore the noise. The story here is still pricing power, and it's insane.
Mortgage revenue up 96% YoY on a ~100% price increase with low-single-digit volume growth. That's a 44x P/E stock printing 84% gross margins. Wolfe is sticking with Outperform and a $1,450 PT (24x CY27 EPS of $59.95). The raise is conservative on volume, but that's fine – they're layering price in throughout the year.
"Fair Isaac's year-over-year mortgage revenue increased 96% despite a roughly 100% price increase and low-single-digit mortgage volume growth."
Guidance assumes flat mortgage volumes in Q4. If rates cooperate even a little, that's upside. The Data, Logic and Products program approval is a near-term catalyst. Pulte returning from interim role provides continuity.
The 44x P/E multiple is the bogey. It prices in perfection. But this isn't a growth stock – it's a tollbooth with a pricing lever that management is pulling aggressively. The after-hours selloff on debt concerns feels like a gift for anyone with a 12-month horizon.
Verdict: Q2 beat is real, but a CEO resignation and cautious guide mean this is a show-me story. Tigress sees $18, but most of the Street is neutral or worse — stock sits at $8 for a reason.
Tigress Financial raised its PT to $18 (Buy) — the outlier — pointing to the first positive ROIC print, robotaxi milestones with VW/Uber/Lyft, and Surround ADAS momentum. Piper Sandler upgraded to $12 (Overweight) on the same robotaxi optionality. Canaccord also went $12 but flagged rising China competition. Meanwhile UBS and Mizuho cut to $9 and $8 (Neutral) after Amnon Shashua announced his departure as CEO. The Q2 beat ($0.19 vs $0.06 est, rev $508M vs $482M) was overshadowed by the cautious near-term outlook and leadership transition.
"Mobileye’s return on capital turned positive for the first time." — Tigress Financial
Bear case writes itself: CEO exiting, cautious guide, structural China threat. Bull case leans on Mentee program execution and robotaxi timelines staying intact — both big "ifs." For a multi-manager book, this is low-conviction, too much uncertainty to size up. Wait for Q3 print for conviction.
B.Riley cut PT to $305 from $340 (still Buy) after a mixed FQ1 print. Revenue beat their estimate but missed consensus; EBITDA missed both. The stock got slammed – down 28.7% in a week – but the narrative isn't broken. Data Centers revenue grew 90% YoY with backlog nearly doubling year-over-year. The margin miss is a timing issue (supply constraints pinching production capacity), not demand destruction.
"Modine reported another record quarter of data center order intake with backlog nearly doubling year-over-year."
Multiple other firms (DA Davidson, GLJ, UBS) recently raised PTs to $330–$428 off the same data center tailwinds and that $4B hyperscaler commitment. So the B.Riley cut is more about multiple compression (20x from 22x) and near-term noise than thesis derailment. Reaffirmed FY27 guidance keeps the long-term setup intact. Risk/reward looks interesting at $9.5B market cap if they execute through the supply hiccups.
Needham cuts PT to $168 from $175, keeps Buy. Modest trim on estimate adjustments — not thesis damage. The beat and raise matters more: Q2 revenue +11% YoY (Street was at 6.9%), Q3 guide midpoint +11% vs consensus 2.4%. Stock +10% in the past week but still -20% YTD. The cut feels like accounting mechanics after a strong print.
Broad-based demand across retail apparel, general merchandise, logistics, and food. Endpoint IC momentum in apparel continues. That’s not a one-off beat — it’s a pattern. Needham sees a good setup into 2027, even accounting for normal Q4 seasonality.
"The positive tone suggests a solid finish to 2026, even after normal seasonality in the fourth quarter."
PT cut is noise. Real signal: Q2 was a record on revenue, adj EBITDA, and non-GAAP EPS. Guidance implied acceleration relative to consensus. The stock’s YTD drawdown reflects earlier macro/sector rotation, not fundamental decay. If the demand breadth sustains (and the article says it’s broad-based), PI is cheap relative to its growth trajectory.
Risk: A single firm trim after a beat is unusual — might signal conservatism on H2 estimates beyond the guide. Worth watching if more analysts follow. But for now, the rate of change is positive, and the narrative is intact.
iPhone is a money machine, but services deceleration is the real conversation. June quarter beat on both top and bottom lines — REVENUE $109.4B (+16% YoY), EPS $2.02 vs Street $1.89 (including 11c tariff refund). iPhone revenue +21.7% to $54.3B, Mac +28.7% to $10.4B (Neo launch tailwind). Services? The blemish: growth decelerated to 12.1% from 16.3% prior quarter, missing $31.4B estimate.
Apple reported revenue of $109.4 billion and earnings per share of $2.02, compared with Wall Street expectations of $109.0 billion and $1.89.
Analyst consensus is quietly bifurcated. Evercore stays Outperform, $365 — likes the iPhone cycle and margin beat (50.1% vs 48.1% est, though 2pts tariff-boosted). Baird bumps to $330, Outperform, citing strong iPhone and steady services. KeyBanc sticks Underweight — worried about slowing unit/user growth. Wolfe positive on the broader beat. China/Europe leading geos at +22% each. The bull case hinges on services re-acceleration; the bear case says that’s a structural headwind. $4.89T market cap — r/r is getting tighter.
BMO stays locked in at Outperform, PT to $164 — that's ~24% upside from $132 after last week's 17% rip. Thesis isn't complicated: the sales transformation they torched last year is finally showing in the numbers. Q3 beat on ARR and FCF, they raised Q4 ARR exit-rate guidance, and the narrative is shifting from "will the transformation work?" to "how fast can deferred ARR convert?" The revenue miss ($600M vs $614M consensus) is a real blemish, but the market didn't care — recurring momentum trumped the headline miss. BMO sees FY27 ARR acceleration on steady execution plus deferred recognition.
"PTC is well-positioned as customers modernize their product data infrastructure to harness AI innovations."
The AI tailwind is real (industrial digital twin / PLM data layer), but the base case is already in the stock after the move. The r/r from here depends on whether Q4 ARR guidance is sandbagged — and whether the sales team can hold the new-cadence through a choppy macro. Piotroski Score of 9 and 85% gross margins are nice structural supports, but PMs should watch the next print for ARR conversion velocity, not just the revenue line.
Bernstein staying bullish on HUBB after a clean Q2 beat. EPS of $5.52 cleared consensus by 3%, guidance raised to $20.40 (4% midpoint hike). Utility segment grew 6% organically. The headline story: grid infrastructure decelerated to 7% from 12% (transmission/substation moderation) but distribution ramped to double digits. Grid automation only 2% as meters stabilized. Net-net, the easing in transmission is normalizing from an elevated base — not rolling over.
The real signal is in the book-to-bill. First-half hit 1.2x, quoting activity is up, and project sizes are getting larger. Backlog is pushing into 2027 for bigger jobs.
"Backlog visibility is extending with delivery dates pushing to 2027 for some larger projects."
Bernstein reiterates Outperform / $584 target. The deceleration in transmission is a near-term speedbump, not a thesis-breaker — distribution acceleration and expanding electrical segment margins (H2) provide offset. Overvaluation flag from InvestingPro fair value, but nobody pins a 27.7x utility/electrification compound on short-cycle multiples. PMs should watch quoting trends as the rate-of-change indicator here.
The 14% drop is an overreaction to noise. DA Davidson holding firm at Buy / $175 while the stock sits at $122. Subscription NNARR printed $39.6M vs $37.5M consensus — and that's with FX headwinds. At constant currency, that number was low-$40M range, exactly where investors wanted it. Gross margin of 81% tells you the SaaS flywheel is real.
The bear case is understandable but not clean. The unchanged FY27 ARR guide is spooking people. Some read it as hardware/supply chain getting worse versus 90 days ago. DA Davidson pushes back explicitly — says that conclusion "is not entirely clear from the results." Management also stated the guide would've been unchanged even without FX. That's a function of conservatism, not deterioration.
"Some market participants interpreted the guidance as suggesting hardware and supply chain challenges may have worsened compared to expectations from 90 days ago. DA Davidson noted this conclusion is not entirely clear from the results."
The whisper number was simply too high. Jefferies cutting to $130 / Hold on "elevated expectations" is the real story here. NNARR was a beat vs consensus, but a miss vs the dreams baked into a stock up 37% in six months. Guggenheim held at $175, citing "in-line to better topline and stronger bottom line." Scotiabank went to $130 / Sector Perform but that's an upgrade from $110 — they're chasing the print down, not cutting on fundamentals.
Verdict: The narrative is messy (drop after a beat/full-year guide hold) but the underlying data is clean — SaaS ARR, gross margin, earnings beat. This is a "buy the panic" setup if you believe the FX story is temporary and management is just playing the guide-down game. Not a conviction position, but the r/r at $122 with $175 PTs from multiple shops is asymmetric. Wait for the stock to find a bid before layering in.
Bernstein bumps PT to $214 from $207, stays Outperform. Nothing flashy – Q2 beat was modest, guidance raised ~1% on FX tailwinds, CoreSite strength, and pass-through adjustments. Organic tenant billings +2% headline, but strip out DISH and you’re ~4%, same mid-single digit clip as last quarter.
The tower sector’s trading at low multiples, and AMT’s controlling what it can. BMO goes to $195, Scotia to $220 with Sector Outperform – collective shrug-to-positive. Not a breakout story, but steady r/r for a 4.2% yield.
“Growth adjusted for DISH remained in the mid-single digits, similar to the prior quarter.”
The CoreSite AI tailwind (13% revenue growth) is the real engine – that’s the part worth watching. AMT’s not exciting, but it’s not broken either. PMs looking for safe income with a hint of data center exposure can do worse.
BofA lifts PT to $198 from $185, Buy maintained. The call is about execution – incremental margins north of 30% organically, AI revenue now ~$2.4B (27% of total), and the CommScope acquisition crushing initial expectations ($4.6B rev vs prior $4.1B, EPS contribution doubled to $0.30). The tape is pricing in sustained double-digit organic growth + M&A torque. Evercore and TD Cowen also reiterate positive stances (Outperform, $180 and $175 respectively), but BofA is the most aggressive on the PT.
"Strong execution, sustained incremental margins above 30% on an organic basis, sustained double-digit organic growth, and a successful acquisition program aided by AI-driven demand."
Margin math holds up even ex-tariff recovery (28.9% OM, 39% QoQ incremental). Not sure the stock is cheap at these levels (trading ~35x forward?), but the rate of change in AI content + CommScope synergies gives the bull case room to run. Watch for any deceleration in organic growth – that’s the bear’s wedge.
AMZN – AWS acceleration to 37% YoY, $169B run rate, $496B backlog. But $220B capex hike explicitly due to memory costs – hyperscalers are price-inelastic. FCF flipped to -$7.6B TTM. The narrative is demand-pull capex, but memory suppliers capture the pricing power. Trainium now a credible long-term ceiling on NVDA merchant GPU share, but near-term NVDA demand coexists.
MU – Apple's Cook called memory pricing a "100-year flood." AMZN added $20B to capex due to memory inflation. Demand so strong AMZN said it can't satisfy all 2026 need even at $220B. SK Hynix raised 2026 capex ~50% YoY but stock fell – that's an artifact of hyperscaler double-ordering fear, not demand cracking. The memory trade is prosocial: price signals driving necessary supply.
COHU – AI test capacity is the new binding constraint on AI chip shipments. Raised 2026 HPC outlook to $100-110M, sees $850M annual customer spend pool. Eclipse lead times at 13-14 weeks confirm supply can't meet demand. 2027 capacity could double HPC revenue to $200-250M. Industrial orders +87% YoY – recovery broadening beyond AI.
AXTI – Record revenue $47.6M, InP revenue $30.7M. Gross margins expanded from 29.9% to 45.0% in one quarter, targeting 50%+. Backlog well over $100M. Customer prepayments of ~$48M confirm extreme seller's market in InP substrates – economic rent transferring upstream from transceiver makers. "Whatever we can produce, we can sell." China >50% of revenue, domestic shipments exempt from export permits.
ASE (ASX) – Q2 revenue NT$191B, EPS NT$4.8 (up 177% YoY). Q3 guide +21-22% QoQ. LEAP (advanced packaging) revenue expected to double in 2027. Increased 2026 capex by another $2B to ~$10.5B – 40% of equipment budget on test. ASE says "has not experienced a comparable manufacturing constraint in 40 years." Legacy wire bond also tight – this is an ecosystem-level bottleneck, not just CoWoS.
LRCX – QJun26 record revenue $6.72B, beat. QSep guide $8.1B (+20% QoQ). Fourth consecutive record quarter. CY26 WFE raised to low-$150B range. Advanced packaging revenue growth raised to +70% YoY. CSBG (spares/services) record $2.5B. NAND systems revenue more than doubled QoQ. The breadth across logic, memory, and packaging is unprecedented – not just an AI trade.
INTC – Maintains 2027 foundry breakeven. 18A yield reportedly matching TSMC by year-end. Analysts see $1+ EPS quarters in 2027 from foundry breakeven plus 50% DC CPU growth. Google ordered 3M+ custom TPUs for 2028 using Intel EMIB packaging – validates Intel's packaging IP as strategically valuable. TSMC developing EMIB-like tech, confirming Intel's lead in this subsegment.
NVDA – AMZN explicitly reaffirmed deep partnership, expects NVIDIA to be primary accelerator "for as long as we can foresee." Tom Lee notes 16x forward earnings vs 70% revenue growth – cheapest multiple in a decade. Long-term risk from custom silicon is real but aggregate AI spending growing fast enough for coexistence. The Situational Awareness forced liquidation dented the stock, but fundamental signals strengthened with every hyperscaler print.
AVGO – Cohu's disclosure of 19-20 customers developing custom ASICs is a direct read-through for Broadcom's custom silicon business. AXT's InP substrate shortage validates the 800G to 1.6T switch ASIC cycle. Broadcom's Tomahawk and Jericho benefit from increased data center traffic. Custom silicon pipeline plus networking growth = multi-year tailwind.
GOOGL – Raised 2026 capex to $195-205B, market punished while MSFT rewarded for holding flat. Depreciation efficiency worse than META's – $7.1B D&A on $321B PP&E vs META's $6.4B on $226B. But TPU v9 plans for 2028 at 12-15M units using Intel EMIB – that's a capacity diversification story and a validation of Intel's packaging. Google Cloud run rate ~$99B, growth accelerating to 82% YoY.
FORM – Dropped ~5% then reversed +17% after hours on a beat. Same week SK Hynix fell on record earnings – opposite reactions say test equipment demand is not priced in. HBM4/HBM4E transition increases probe card complexity. Positive price action a street-level signal that test cycle is accelerating.
SMCI – Launched new AI rack series under DCBBS portfolio, can deliver up to 3,000 AI racks per month. Scaling liquid-cooled rack capacity to meet hyperscaler demand. Rack-level integration is a key value add. Beneficiary of Nvidia's GPU supply ramp.
SMTC – Controls 50% of 800G TIA market share. 1.6T TIA coming 2-3 quarters ahead of competitor MXL. Positive on LPO demand. Custom ASIC shift benefits both SMTC and MXL. Down 20% from pitch price – optical cycle acceleration provides multi-quarter catalyst.
PWR – Record backlog ~$53B. Gas turbine lead times at 5-6 years. ~95% of larger generation work not yet in backlog – transmission cycle hasn't entered at scale. Can "book and build $300M on a site in a quarter." Data-center related work 15-20% of business and growing. 800V data-center architecture not yet in RFPs commercially.
RDDT – Q2 beat on revenue and EPS, guide above consensus. But stock fell 11% because of "choppy search referrals" and no new AI data licensing deal announced. Market priced in another catalyst – its absence triggered derating. Core ad business intact but narrative fuel has run dry.
OKTA – Acquired Permiso Security for ~$200M. That's a strategic bolt-on for identity security in cloud/AI agents – a new attack surface. AI agent proliferation creates need for identity management. Private acquisition valuation suggests public security multiples are compressing, but tech is directly relevant.
COIN – Q3 third consecutive revenue miss, down 19% to $1.22B. Trading volumes low, retail engagement weak. Crypto has not been an AI-money beneficiary. Trading fee fundamentals deteriorating. Not a viable AI-adjacent play.
CORT – FDA approval for Lifyorli (hypercortisolism) on March 25. Stock up 226% since Trump trade filing. Idiosyncratic biotech story, no tech read-through. Regulatory catalyst delivered massive alpha. Not a signal for TMT but included for completeness.